Giuseppe De Luca

Showing 1-8 of 8 articles

Coronary interventions

EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI) A branch of the European Society of Cardiology

Van Belle E, Teles RC, Pyxaras S, Kalpak O, Johnson T, Barbash IM, De Luca G, Kostov J, Parma R, Vincent F, Brugaletta S, Debry N, Toth G, Ghazzal Z, Deharo P, Milasinovic D, Kaspar K, Saia F, Mauri J, Kammler J, Muir D, O'Connor S, Mehilli J, Thiele H, Weilenmann D, Witt N, Joshi F, Kharbanda R, Piroth Z, Wojakowski W, Geppert A, Di Gioia G, Pires-Morais G, Petronio AS, Estevez-Loureiro R, Ruzsa Z, Kefer J, Kunadian V, Van Mieghem N, Windecker S, Baumbach A, Haude M, Dudek D

July 7, 2020 | 10.4244/EIJ-D-18-00448

Coronary interventions

Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial)

De Luca G, Damen S, Camaro C, Benit E, Verdoia M, Rasoul S, Liew H, Polad J, Ahmad W, Zambahari R, Postma S, Kedhi E, Suryapranata H

December 6, 2019 | 10.4244/EIJ-D-19-00539

Coronary interventions

Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention: insights from the HORIZONS-AMI trial

Schoos M, De Luca G, Dangas G, Clemmensen P, Ayele G, Mehran R, Stone G

October 20, 2016 | 10.4244/EIJV12I9A186

Coronary interventions

Very high-pressure dilatation for undilatable coronary lesions: indications and results with a new dedicated balloon

Secco G, Ghione M, Mattesini A, Dall’Ara G, Ghilencea L, Kilickesmez K, De Luca G, Fattori R, Parisi R, Marino P, Lupi A, Foin N, Di Mario C

June 20, 2016 | 10.4244/EIJY15M06_04

Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation

De Luca G, Gibson C, Huber K, Dudek D, Cutlip D, Zeymer U, Gyöngyösi M, Bellandi F, Noc M, Arntz H-R, Maioli M, Secco G, Zorman S, Gabriel H, Emre A, Rakowski T, van’t Hof A

August 24, 2012 | 10.4244/EIJV8I4A74

Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials

Navarese E, Kubica J, Castriota F, Gibson M, De Luca G, Buffon A, Bolognese L, Margheri M, Andreotti F, Di Mario C, De Servi S

December 30, 2011 | 10.4244/EIJV7I8A155

Optical coherence tomography for guidance of treatment of in-stent restenosis with cutting balloons

Secco G, Foin N, Msc M, Viceconte N, Borgia F, De Luca G, Di Mario C

November 30, 2011 | 10.4244/EIJV7I7A130

Percutaneous coronary stenting in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis

Biondi-Zoccai G, Moretti C, Abbate A, Lipinski M, De Luca G, Agostoni P, Meliga E, Goudreau E, Vetrovec G, Trevi GP, Sheiban I

November 20, 2007

1

Latest news

PCR e-Course; LM interventions; FFR and STEMI, the EAPCI and COVID-19; TMVR

Ahead of print: EAPCI Core Curriculum for PCI (2020)

IVUS guidance during left main PCI: not if, but when and how

Ahead of print: EAPCI Expert Consensus Document: Ischaemia with non-obstructive coronary arteries

V. Kunadian et al

Left main PCI: are we giving the kiss the attention it deserves?

Find the latest trials:

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

This Week's JAA's: CULPRIT-SHOCK substudy, Coronary Microcatheter Complications...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke